Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model
Open Access
- 20 November 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 16887
Abstract
Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington’s disease (HD). Inhibiting mHtt aggregation reduces cell death in the brain and is thus a promising therapeutic approach. The results of the present study demonstrated that mHtt aggregation in the nucleus was altered by the activity of multidrug resistance protein 1 (MDR1), which was experimentally modulated by verapamil, siRNA and an expression vector. MDR1 detoxifies drugs and metabolites through its excretory functions in the membrane compartment, thereby protecting cells against death or senescence. When they were treated with verapamil, R6/2 mice showed a progressive decline in rotarod performance and increased mHtt aggregation in the brain. Using neuronal stem cells from R6/2 mice, we developed an in vitro HD model to test mHtt accumulation in the nuclei of neurons. When MDR1 activity in cells was decreased by verapamil or siRNA, mHtt aggregation in the nuclei increased, whereas the induction of MDR1 resulted in a decrease in mHtt aggregation. Thus, our data provide evidence that MDR1 plays an important role in the clearance of mHtt aggregation and may thus be a potential target for improving the survival of neurons in Huntington’s disease.Keywords
This publication has 53 references indexed in Scilit:
- Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregationProceedings of the National Academy of Sciences, 2010
- Neural Stem/Progenitor Cells Differentiate In Vitro to Neurons by the Combined Action of Dibutyryl cAMP and Interferon-γStem Cells and Development, 2009
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Normal huntingtin function: an alternative approach to Huntington's diseaseNature Reviews Neuroscience, 2005
- Functional expression of ABCG2 transporter in human neural stem/progenitor cellsNeuroscience Research, 2005
- Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disordersNature, 2003
- Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's DiseaseJournal of Neuroscience, 2002
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicityHuman Molecular Genetics, 2000
- Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In VivoCell, 1997